Drug Formulary

The drug library provides access to information on over 100 cancer drugs available for use in Canada.

Find more safety information in the supplementary patient handouts:

Download how to Safely Take Your Oral Anti-Cancer Medication

Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.

Funded Evidence-informed Regimens

Drug and regimen monographs and information sheets for patients provide information on dosing and administering cancer treatment protocols. They are for general reference and are not meant to replace prescribing information or physician recommendations.

For patient information about regimens that include both chemotherapy and immunotherapy, download Treating cancer with chemotherapy and immunotherapy: What you need to know.

If you have questions about ST-QBP funding on our website, please visit our Frequently Asked Questions page.

Find enhanced Regimen Patient Information Sheets, created in collaboration with patient and family advisors.

What's New - Drugs

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

What's New - Regimens

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Last Updated: August 17, 2026

The information on this website is intended for informational purposes only and is not a substitute for medical advice. Always consult your health care provider if you have questions or concerns. The use of the information on this website does not create a physician-patient relationship between Ontario Health and you.
Ontario Health is committed to ensuring accessible services and communications to individuals with disabilities. To receive any information on this website in an alternate format, please contact Ontario Health’s Communications Department at: 1-877-280-8538,TTY 1-800-855-0511, or by email at info@ontariohealth.ca.

Drug Formulary

Filters

Filters

Cancer Type

nid

Date

abemaciclib

abiraterone

acalabrutinib

AFAtinib

aflibercept

aldesleukin

alectinib

alemtuzumab

alpelisib

amivantamab

amsacrine

anagrelide

anastrozole

apalutamide

aprepitant / fosaprepitant

arsenic trioxide

asciminib

atezolizumab

atezolizumab (subcut)

avelumab

aXitinib

azaCITIDine

azaCITIDine (tablets)

BCG

belzutifan

bendamustine

bevacizumab

bicalutamide

binimetinib

bleomycin

blinatumomab

bortezomib

bosutinib

brentuximab vedotin

brigatinib

buserelin

busulfan

cabazitaxel

cabozantinib (tablet)

calaspargase pegol

capecitabine

capivasertib

CARBOplatin

carfilzomib

carmustine

cemiplimab

ceritinib

cetuximab

chlorambucil

CISplatin

cladribine

clodronate

cobimetinib

crisantaspase recombinant

crizotinib

cyclophosphamide

cyproterone

cytarabine

daBRAFenib

dacarbazine

dacomitinib

DACTINomycin

daratumumab

daratumumab (subcut)

darbepoetin

darolutamide

daSATinib

DAUNOrubicin

decitabine / cedazuridine

degarelix

denosumab

dexamethasone

dexrazoxane

dinutuximab